Creatv Bio also published the fact that they were hired to do several studies with CytoDyn besides the colon cancer one. So there is clearly a path towards at least one other study and so it's just a matter of time for that announcement. The question I ask myself is "What is management doing or needs to do to get us into that study. Where will that study be taking place (USA or elsewhere)? Is management over in Europe to finalize the study there?

So many unknowns. Would be nice to get some kind of update on what's happening in the near term and long term. The wheels are a turning...